RIO Stock Recent News

ALMA, Canada--(BUSINESS WIRE)--Rio Tinto is investing US$1.2 billion (CA$1.7 billion) to modernise its Isle-Maligne hydroelectric power plant, commissioned in 1926 in Alma, Quebec. This is Rio Tinto's largest single investment in its hydroelectric assets since the 1950s. The power plant modernisation is essential to secure the future of low-carbon aluminium production in Saguenay–Lac-Saint-Jean, supporting the jobs of employees across the region. It will allow Rio Tinto to protect its assets fo.

CNBC's Pippa Stevens joins 'Squawk on the Street' with an inside look at one of the largest copper mines in the U.S.

PERTH, Australia--(BUSINESS WIRE)--Rio Tinto and Sumitomo Metal Mining Co (SMM) have signed the final joint venture agreements to deliver the Winu copper-gold project, located in the Great Sandy Desert region of Western Australia. The final joint venture agreements were signed in Perth by Rio Tinto Copper Chief Executive Katie Jackson and SMM Director, Managing Executive Officer, and General Manager of the Mineral Resources Division Hideyuki Okamoto. It comes after the two companies signed a Te.

Clinton, New York, May 07, 2025 (GLOBE NEWSWIRE) -- Indium Corporation and Rio Tinto Announce Groundbreaking Milestone in Gallium Extraction Partnership

President Trump has made a new announcement, calling for a certain industry to start moving to meet new demand caused by recent trade tariff rollouts. This has likely been analyzed deeply by some of the best and smartest traders in the market today.

LONDON--(BUSINESS WIRE)--Palliser Capital highlights that their campaign for a transparent and independent review of the unification of Rio Tinto's archaic dual listed company (“DLC”) structure has served a critical purpose. It has promoted the need for better governance standards at Rio Tinto and catalyzed an improved understanding of the case for unification, despite the resolution failing to achieve sufficient shareholder support at Rio Tinto's 2025 AGM. Palliser reaffirms their continued co.

PERTH, Australia—Rio Tinto shareholders voted against an independent review of the miner's dual-listed structure, rejecting an activist investor's proposal aimed at getting the company to drop a decades-old primary London listing.

Since my last analysis, new tariffs announced by President Trump have added additional – and large – uncertainties to mining stocks. I expect high tariffs to disrupt global trade flows, decrease demand for basic metals, and increase operational costs for both RIO and VALE. As a reflection of these macroscopic pressures, the latest data show that both companies are experiencing elevated inventory.

Livium Ltd is in advanced negotiations to secure a new contract with national metal recycler Sell & Parker Pty Ltd that is expected to generate revenue exceeding A$1 million. The Proposed Agreement would represent approximately 15% of Livium’s total revenue for the 2024 financial year, marking a significant step forward in the company’s commercial strategy. Sell & Parker is a nationally recognised metal recycling business, employing more than 400 people across eight facilities nationwide. Aiming to diversify end-of-life battery sources Under the terms of the Proposed Agreement, Livium’s wholly owned subsidiary Envirostream Australia Pty Ltd would provide recycling services for project-related materials, with operations expected to start in late April 2025. The contract is expected to drive a substantial uplift in collection volumes through the remainder of the 2025 financial year and into the first half of FY26, with the potential for an extended partnership. While the agreement

Lumos Diagnostics Holdings Ltd has achieved a significant milestone in the commercial rollout of its FebriDx® rapid diagnostic test in the United States, securing reimbursement coverage with two of the seven Medicare Administrative Contractors (MACs). The approved reimbursement rate of US$41.38 per test will take effect from April 2025. Medicare plays a critical role in the US healthcare reimbursement system, accounting for between 20% and 24% of the national payor mix. Securing MAC-level reimbursement is a key gateway to broader market access, including acceptance by private insurers who often follow Medicare’s lead. Lumos is currently in advanced negotiations with three of the remaining five MACs. The FebriDx® test, manufactured in the United States, provides rapid, point-of-care results to help clinicians differentiate between bacterial and viral causes of acute respiratory infections in approximately 10 minutes. This timely information supports antimicrobial stewardship by redu